Condition
Gastrointestinal Malignancy
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07211386Not ApplicableRecruitingPrimary
The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT)
NCT06538610Not ApplicableRecruitingPrimary
The 5-FU Holter Study
NCT02007876Not ApplicableWithdrawnPrimary
Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients
Showing all 3 trials